Found: 25
Select item for more details and to access through your institution.
A Systematic Approach to Optimize the Implementation of Precision Oncology in Clinical Practice: A Meeting Proceeding.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 210, doi. 10.36401/JIPO-23-41
- By:
- Publication type:
- Article
Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.749786
- By:
- Publication type:
- Article
Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0076984
- By:
- Publication type:
- Article
Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Vascular Smooth Muscle Cells From Hypertensive Patient-Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics.
- Published in:
- Stem Cells Translational Medicine, 2015, v. 4, n. 12, p. 1380, doi. 10.5966/sctm.2015-0126
- By:
- Publication type:
- Article
Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine.
- Published in:
- Stem Cells, 2017, v. 35, n. 3, p. 545, doi. 10.1002/stem.2570
- By:
- Publication type:
- Article
Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome‐Wide Interaction Meta‐Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 3, p. 723, doi. 10.1002/cpt.2355
- By:
- Publication type:
- Article
Opportunity for Genotype‐Guided Prescribing Among Adult Patients in 11 US Health Systems.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 1, p. 179, doi. 10.1002/cpt.2161
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1417, doi. 10.1002/cpt.2015
- By:
- Publication type:
- Article
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype‐Derived Activity Scores.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 12, p. 678, doi. 10.1002/psp4.12563
- By:
- Publication type:
- Article
Genome-Wide Meta-Analysis of Blood Pressure Response to β<sub>1</sub>-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Genome-wide study of resistant hypertension identified from electronic health records.
- Published in:
- PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0171745
- By:
- Publication type:
- Article
Genetics of Resistant Hypertension: a Novel Pharmacogenomics Phenotype.
- Published in:
- Current Hypertension Reports, 2015, v. 17, n. 9, p. 1, doi. 10.1007/s11906-015-0583-8
- By:
- Publication type:
- Article
Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 12, p. e2029411, doi. 10.1001/jamanetworkopen.2020.29411
- By:
- Publication type:
- Article
β<sub>2</sub>‐Adrenergic Receptor Gene Affects the Heart Rate Response of β‐Blockers: Evidence From 3 Clinical Studies.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 11, p. 1462, doi. 10.1002/jcph.1443
- By:
- Publication type:
- Article
Reply to "A call for reporting of tumor‐specific outcomes in studies of DPYD genotyping".
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.70008
- By:
- Publication type:
- Article
Pharmacogenomics polygenic risk score: Ready or not for prime time?
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.13893
- By:
- Publication type:
- Article
Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 2, p. 1, doi. 10.1111/cts.13704
- By:
- Publication type:
- Article
A randomized, cross‐over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 7, p. 1764, doi. 10.1111/cts.13294
- By:
- Publication type:
- Article
Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 558, doi. 10.1111/cts.13176
- By:
- Publication type:
- Article
Multi‐site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 1, p. 268, doi. 10.1111/cts.12854
- By:
- Publication type:
- Article
Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 3, p. 473, doi. 10.1111/cts.12729
- By:
- Publication type:
- Article
Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 1, p. 195, doi. 10.1111/cts.12702
- By:
- Publication type:
- Article
Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta‐Blockers in European Americans.
- Published in:
- CTS: Clinical & Translational Science, 2019, v. 12, n. 5, p. 497, doi. 10.1111/cts.12643
- By:
- Publication type:
- Article